Table 1.
ALL (n=126) | Low grade stenosis (<50%, n=46) | High grade stenosis (≥50%, n=80) | p value | |
---|---|---|---|---|
Age | 61.5±10.0 | 63.70±9.4 | 60.3±10.1 | 0.07 |
Sex (male) | 82 (65.1%) | 33(71.7%) | 49(61.3%) | 0.23 |
Diabetes | 42 (33.3%) | 15 (32.6%) | 27 (33.8%) | 0.90 |
Smoking | 35 (27.8%) | 13 (28.3%) | 22 (27.5%) | 0.93 |
Hypertension | 101(80.2%) | 37 (80.4%) | 64 (80.0%) | 0.96 |
Hyperlipidemia | 65 (51.6%) | 18 (39.1%) | 47 (58.8%) | 0.03* |
Coronary Artery Disease | 5 (4.0%) | 3 (6.5%) | 2 (2.5%) | 0.27 |
Pre-admission Aspirin use | 31 (24.6%) | 9 (19.6%) | 22 (27.5%) | 0.32 |
Pre-admission Statin use | 17 (13.5%) | 4 (8.7%) | 13 (16.3%) | 0.23 |
NIHSS score (median and range) | 1 (0,11) | 2 (0,11) | 0(0,6) | <0.001* |
Degree of Stenosis (%) | 52.6±15.8 | 35.2±9.7 | 62.6±7.9 | <0.001* |
Enhancement Percentage (%) | 17.4±28.4 | 21.1 ±33.1 | 15.3 ±25.3 | 0.27 |
Intraplaque Haemorrhage | 22 (17.5%) | 9 (19.6%) | 13(16.3%) | 0.63 |
Minimum Lumen Area | 3.2±2.97 | 5.1±3.4 | 2.1±1.3 | <0.001* |
Plaque Burden (%) | 84.0±9.1 | 75.9±8.2 | 88.6±5.7 | <0.001* |
Symptomatic | 66 (52.4%) | 28(60.9%) | 38 (47.5%) | 0.15 |
NIHSS: National Institute of Health Stroke Scale
Statistically significant